Search this journal
Advanced search
Home
Current issue
Browse archive
Alerts
About the journal
Feedback
JRSM
>
Volume 98, Number 10
> Pp. 448-450
J R Soc Med 2005;
98
:448-450
doi:10.1258/jrsm.98.10.448
© 2005 Royal Society of Medicine
This Article
Full Text
Full Text
(PDF)
Send a Quick Comment
Alert me when this article is cited
Alert me when Quick Comments are posted
Alert me if a correction is posted
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via Google Scholar
Google Scholar
Articles by Wager, E.
Search for Related Content
PubMed
PubMed Citation
Social Bookmarking
What's this?
A concern that drug companies cannot ignore
Elizabeth Wager
You have reached the most complete version of this article accessible without further authentication.
More complete versions are available.
Link to article
Article topics:
Political Science..Parliaments
Pharmacology..Drug Industry
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
What's this?
This Article
Full Text
Full Text
(PDF)
Send a Quick Comment
Alert me when this article is cited
Alert me when Quick Comments are posted
Alert me if a correction is posted
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via Google Scholar
Google Scholar
Articles by Wager, E.
Search for Related Content
PubMed
PubMed Citation
Social Bookmarking
What's this?